Keisuke Mitamura

Senior Scientist, Research Division at Kyowa Kirin

Speaker

Keisuke Mitamura received his M.E. in biomolecular engineering from Institute of Science Tokyo. He started his career at Kyowa Kirin Co., Ltd. (KKC) and engaged in antibody engineering and development to apply REGULGENT™, KKC’s proprietary bispecific antibody technology, for pipeline products. He worked as a project leader of KK2260, one of the REGULGENT™-applied pipeline products of KKC, which started the phase 1 clinical study from 2023. He currently is a senior reseach scientist at the Bio-Pharmaceutical Center of KKC, leading the discovery, engineering, and laboratory automation of antibody and other biologics.